194 related articles for article (PubMed ID: 15485823)
1. Cooperative interaction between the basic helix-loop-helix transcription factor dHAND and myocyte enhancer factor 2C regulates myocardial gene expression.
Zang MX; Li Y; Wang H; Wang JB; Jia HT
J Biol Chem; 2004 Dec; 279(52):54258-63. PubMed ID: 15485823
[TBL] [Abstract][Full Text] [Related]
2. Cooperative activation of atrial naturetic peptide promoter by dHAND and MEF2C.
Zang MX; Li Y; Xue LX; Jia HT; Jing H
J Cell Biochem; 2004 Dec; 93(6):1255-66. PubMed ID: 15486975
[TBL] [Abstract][Full Text] [Related]
3. The transcription factors GATA4 and dHAND physically interact to synergistically activate cardiac gene expression through a p300-dependent mechanism.
Dai YS; Cserjesi P; Markham BE; Molkentin JD
J Biol Chem; 2002 Jul; 277(27):24390-8. PubMed ID: 11994297
[TBL] [Abstract][Full Text] [Related]
4. Transcription enhancer factor 1 interacts with a basic helix-loop-helix zipper protein, Max, for positive regulation of cardiac alpha-myosin heavy-chain gene expression.
Gupta MP; Amin CS; Gupta M; Hay N; Zak R
Mol Cell Biol; 1997 Jul; 17(7):3924-36. PubMed ID: 9199327
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with nonischemic heart failure.
Razeghi P; Young ME; Cockrill TC; Frazier OH; Taegtmeyer H
Circulation; 2002 Jul; 106(4):407-11. PubMed ID: 12135937
[TBL] [Abstract][Full Text] [Related]
6. GATA-dependent recruitment of MEF2 proteins to target promoters.
Morin S; Charron F; Robitaille L; Nemer M
EMBO J; 2000 May; 19(9):2046-55. PubMed ID: 10790371
[TBL] [Abstract][Full Text] [Related]
7. A GATA-dependent right ventricular enhancer controls dHAND transcription in the developing heart.
McFadden DG; Charité J; Richardson JA; Srivastava D; Firulli AB; Olson EN
Development; 2000 Dec; 127(24):5331-41. PubMed ID: 11076755
[TBL] [Abstract][Full Text] [Related]
8. Load-induced transcriptional activation of c-jun in rat myocardium: regulation by myocyte enhancer factor 2.
Nadruz W; Kobarg CB; Constancio SS; Corat PD; Franchini KG
Circ Res; 2003 Feb; 92(2):243-51. PubMed ID: 12574153
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.
Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; Macleod RA
Leuk Lymphoma; 2011 Feb; 52(2):290-7. PubMed ID: 21261500
[TBL] [Abstract][Full Text] [Related]
10. The basic helix-loop-helix transcription factors dHAND and eHAND exhibit dimerization characteristics that suggest complex regulation of function.
Firulli BA; Hadzic DB; McDaid JR; Firulli AB
J Biol Chem; 2000 Oct; 275(43):33567-73. PubMed ID: 10924525
[TBL] [Abstract][Full Text] [Related]
11. MEF2-dependent recruitment of the HAND1 transcription factor results in synergistic activation of target promoters.
Morin S; Pozzulo G; Robitaille L; Cross J; Nemer M
J Biol Chem; 2005 Sep; 280(37):32272-8. PubMed ID: 16043483
[TBL] [Abstract][Full Text] [Related]
12. Myocyte-specific enhancer-binding factor (MEF-2) regulates alpha-cardiac myosin heavy chain gene expression in vitro and in vivo.
Molkentin JD; Markham BE
J Biol Chem; 1993 Sep; 268(26):19512-20. PubMed ID: 8366095
[TBL] [Abstract][Full Text] [Related]
13. Myocyte-specific enhancer factor 2 and thyroid hormone receptor associate and synergistically activate the alpha-cardiac myosin heavy-chain gene.
Lee Y; Nadal-Ginard B; Mahdavi V; Izumo S
Mol Cell Biol; 1997 May; 17(5):2745-55. PubMed ID: 9111345
[TBL] [Abstract][Full Text] [Related]
14. Targeted deletion of a branchial arch-specific enhancer reveals a role of dHAND in craniofacial development.
Yanagisawa H; Clouthier DE; Richardson JA; Charité J; Olson EN
Development; 2003 Mar; 130(6):1069-78. PubMed ID: 12571099
[TBL] [Abstract][Full Text] [Related]
15. Role of myocyte-specific enhancer-binding factor (MEF-2) in transcriptional regulation of the alpha-cardiac myosin heavy chain gene.
Adolph EA; Subramaniam A; Cserjesi P; Olson EN; Robbins J
J Biol Chem; 1993 Mar; 268(8):5349-52. PubMed ID: 8449897
[TBL] [Abstract][Full Text] [Related]
16. A subclass of bHLH proteins required for cardiac morphogenesis.
Srivastava D; Cserjesi P; Olson EN
Science; 1995 Dec; 270(5244):1995-9. PubMed ID: 8533092
[TBL] [Abstract][Full Text] [Related]
17. Myocyte enhancer factors-2B and -2C are required for adhesion related kinase repression of neuronal gonadotropin releasing hormone gene expression.
Allen MP; Xu M; Zeng C; Tobet SA; Wierman ME
J Biol Chem; 2000 Dec; 275(50):39662-70. PubMed ID: 10995769
[TBL] [Abstract][Full Text] [Related]
18. The combinatorial activities of Nkx2.5 and dHAND are essential for cardiac ventricle formation.
Yamagishi H; Yamagishi C; Nakagawa O; Harvey RP; Olson EN; Srivastava D
Dev Biol; 2001 Nov; 239(2):190-203. PubMed ID: 11784028
[TBL] [Abstract][Full Text] [Related]
19. Myocyte enhancer factor-2 and serum response factor binding elements regulate fast Myosin heavy chain transcription in vivo.
Allen DL; Weber JN; Sycuro LK; Leinwand LA
J Biol Chem; 2005 Apr; 280(17):17126-34. PubMed ID: 15728583
[TBL] [Abstract][Full Text] [Related]
20. Control of cardiac-specific transcription by p300 through myocyte enhancer factor-2D.
Slepak TI; Webster KA; Zang J; Prentice H; O'Dowd A; Hicks MN; Bishopric NH
J Biol Chem; 2001 Mar; 276(10):7575-85. PubMed ID: 11096067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
